Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 6,512.00
+73.50 (1.14%)
Oct 29, 2025, 3:29 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.73 trillion as of October 29, 2025. Its market cap has increased by 8.72% in one year.
Market Cap
1.73T
Enterprise Value
1.69T
Revenue
96.52B
Ranking
n/a
PE Ratio
75.01
Stock Price
6,512.00
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.73T, an increase of 84,828.41%. That is a compound annual growth rate of 34.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 1.71T | 5.57% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | 1.02T | 108.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.08T |
| Cipla | 1.28T |
| Apollo Hospitals Enterprise | 1.13T |
| Zydus Lifesciences | 1.01T |
| Mankind Pharma | 1.00T |
| Fortis Healthcare | 783.12B |
| Alkem Laboratories | 662.99B |
| Aurobindo Pharma | 630.17B |